We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
151
O'Reilly Automotive
ORLY
$72.4B
$3.15M 0.06%
168,870
-90
-0.1% -$1.69K
RLI icon
152
RLI Corp
RLI
$5.68B
$3.1M 0.06%
90,594
+2
+0% +$69
IVV icon
153
iShares Core S&P 500 ETF
IVV
$876B
$3.08M 0.06%
14,155
+1,120
+9% +$244K
DD
154
DELISTED
Du Pont De Nemours E I
DD
$3.08M 0.06%
45,920
-201
-0.4% -$13.7K
PFF icon
155
iShares Preferred and Income Securities ETF
PFF
$13.2B
$3.06M 0.06%
77,585
-7,332
-9% -$293K
CSCO icon
156
Cisco
CSCO
$450B
$2.95M 0.06%
92,996
+10,902
+13% +$335K
VGK icon
157
Vanguard FTSE Europe ETF
VGK
$30B
$2.88M 0.05%
59,154
+2,035
+4% +$97.9K
MRSH
158
Marsh
MRSH
$86.3B
$2.88M 0.05%
42,750
+620
+1% +$41.5K
ESRX
159
DELISTED
Express Scripts Holding Company
ESRX
$2.87M 0.05%
40,669
-300
-0.7% -$22.4K
RTX icon
160
RTX Corp
RTX
$287B
$2.87M 0.05%
44,816
+203
+0.5% +$13.5K
NVDA icon
161
NVIDIA
NVDA
$5.01T
$2.82M 0.05%
1,645,800
+1,051,400
+177% +$1.55M
DM
162
DELISTED
Dominion Energy Midstream Ptr LP
DM
$2.73M 0.05%
113,998
-6,385
-5% -$165K
DEO icon
163
Diageo
DEO
$46.2B
$2.72M 0.05%
23,406
-458
-2% -$52.4K
GIS icon
164
General Mills
GIS
$19.2B
$2.71M 0.05%
42,390
+626
+1% +$43.6K
XLV icon
165
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$2.68M 0.05%
37,182
-12,084
-25% -$889K
CNI icon
166
Canadian National Railway
CNI
$78.5B
$2.68M 0.05%
40,967
-1,298
-3% -$82K
WEC icon
167
WEC Energy
WEC
$37.7B
$2.67M 0.05%
44,552
-48
-0.1% -$3K
MDY icon
168
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$2.47M 0.05%
8,764
+295
+3% +$83.1K
LULU icon
169
lululemon athletica
LULU
$13B
$2.43M 0.05%
39,896
-17,508
-30% -$1.29M
UNF icon
170
Unifirst Corp
UNF
$5.32B
$2.41M 0.05%
18,263
NVS icon
171
Novartis
NVS
$295B
$2.4M 0.05%
33,977
+1,036
+3% +$75.5K
QQQ icon
172
Invesco QQQ Trust
QQQ
$455B
$2.39M 0.04%
20,124
+5,544
+38% +$640K
KMB icon
173
Kimberly-Clark
KMB
$36.4B
$2.37M 0.04%
18,823
-108
-0.6% -$14K
SAQ.CL
174
DELISTED
Saratoga Investment Corp.
SAQ.CL
$2.31M 0.04%
90,015
-900
-1% -$23.1K
EQNR icon
175
Equinor
EQNR
$95.9B
$2.31M 0.04%
137,596
-34,243
-20% -$556K

Similar funds

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.